Genitourinary Lesions Due to Monkeypox.

BACKGROUND: Since May 2022, 31 000 cases of monkeypox infection have been reported in nonendemic areas. OBJECTIVE: To describe a series of cases of monkeypox with genitourinary involvement. DESIGN, SETTING, AND PARTICIPANTS: This was a prospective observational study of men diagnosed with monkeypox disease with genitourinary involvement. RESULTS AND LIMITATIONS: A total of 14 patients were recruited. The median age was 42 yr. Of these patients, 43% sought a consultation for genitourinary symptomatology, and 71% had engaged in sex with other men. Eight patients (57%) were positive for human immunodeficiency virus, one diagnosed synchronously; the remainder had a median CD4 count of 663/µl. Six patients (43%) had a different sexually transmitted disease. Penile oedema was present in 43% of patients and two patients required surgical exploration. CONCLUSIONS: Genitourinary involvement is frequent in monkeypox disease and is often the reason for the consultation visit. PATIENTS SUMMARY: In this report we looked at how monkeypox disease can affect the genitourinary area, causing swelling of the penis or skin lesions.

Efficacy, tolerance and predictors of response to the treatment with hyperbaric oxygen therapy for patients with hemorrhagic radiation cystitis.

OBJECTIVES: The aim was to study the efficacy and tolerance in patients with haemorrhagic radiation-induced cystitis (HRC) treated with hyperbaric oxygen therapy (HOT) and analyze which factors were related to the response to the treatment. MATERIAL AND METHODS: We performed a retrospective cohort study of patients treated with HOT for HRC symptoms in a provincial referral centre from 2010 to 2020. We evaluated clinical response to treatment, number of hospitalizations due to HRC and subjective response using the PGI-I questionnaire. RESULTS: We treated 52 patients, with a median of 30 sessions, during 6 months and 40 months (6-68 months) of follow-up. 69.2%of patients responded completely and 21,2% partially. The 53.2% of patients improved before the first 10 sessions. Reduction of hospitalizations/per year due to haematuria from 2.8 to 1.1 (p=0,001). The 73,5% of patients stated that they were "very much better" or "much better" after treatment. During the follow-up, 15.4% of patients had recurrence of HRC. 9.6% of the patients required salvage cystectomy. The patients with a highest RTOG-EORTC scale had more risk to still with symptoms (OR 3.01 (IC95 1.48 - 6.16). All patients were able to complete the proposed treatment plan with good tolerance to HOT. CONCLUSIONS: These results show the clinical benefit of HOT in the treatment of HRC, with a reduction of the number of hospitalizations and a subjective improvement.

Efficacy, tolerance and predictors of response to the treatment with hyperbaric oxygen therapy for patients with hemorrhagic radiation cystitis

Objectives: The aim was to study the efficacy and tolerance in patients with haemorrhagic radiation-induced cystitis (HRC)treated with hyperbaric oxygen therapy (HOT) and analyze which factors were related to the response to the treatment.Material and methods: We performed a retrospective cohort study of patients treated with HOT for HRC symptoms in a provincial referral centre from 2010 to 2020. We evaluated clinical response to treatment, number of hospitalizations due to HRC andsubjective response using the PGI-I questionnaire.Results: We treated 52 patients, with a median of 30 sessions, during 6 months and 40 months (6-68 months) of follow-up. 69.2%of patients responded completely and 21,2% partially. The 53.2% of patients improved before the first 10 sessions. Reduction ofhospitalizations/per year due to haematuria from 2.8 to 1.1 (p=0,001). The 73,5% of patients stated that they were “very muchbetter” or “much better” after treatment. During the follow-up, 15.4% of patients had recurrence of HRC. 9.6% of the patientsrequired salvage cystectomy. The patients with a highest RTOG-EORTC scale had more risk to still with symptoms (OR 3.01(IC95 1.48 – 6.16). All patients were able to complete the proposed treatment plan with good tolerance to HOT.Conclusions: These results show the clinical benefit of HOT in the treatment of HRC, with a reduction of the number of hospitalizations and a subjective improvement. (AU)

Objetivo: conocer eficacia y tolerancia de la hiperoxigemia en cámara hiperbárica (THO) en pacientes con cistitis rádica hemorrágica (CRH) y analizar factores asociadosa respuesta al tratamiento.Material y métodos: estudio de cohorte retrospectivode pacientes tratados mediante THO por CRH en centro dereferencia entre 2010 y 2020. Evaluamos respuesta clínicade la hematuria, número de ingresos hospitalarios por CRHy satisfacción subjetiva mediante cuestionario PGI-I.Resultados: tratamos 52 pacientes, mediana de 30 sesiones con 6 meses de tratamiento y 40 meses (6-68 meses)de seguimiento. El 69,2% obtuvo respuesta completa y el21,2% respuesta parcial. El 53,2% mejoró antes de las 10primeras sesiones. La reducción de los ingresos hospitalarios/año por hematuria fue de 2,8 a 1,1 (p=0,001). El 73,5%de pacientes señaló encontrarse “Mucho mejor” o “un pocomejor” tras el tratamiento. Durante el seguimiento, el15,4% presentaron recurrencia de hematuria. Del total dela serie, 9,6% de pacientes precisó cistectomía de rescate.El análisis de supervivencia mostró una asociación entre eltiempo de desaparición de la hematuria y la clasificación dela escala RTOG-EORTC (OR 3,01 (IC95 1,48-6,16). Todoslos pacientes pudieron finalizar el plan de tratamiento propuesto con buena tolerancia a la THO.Conclusiones: la THO muestra beneficio clínico enel tratamiento de la CRH, redujo los episodios de hospitalización por hematuria y mejoró la calidad de vida de lospacientes, con buena tolerancia al tratamiento. (AU)

[Metabolic alterations and stones in patients with orthotopic ileal diversions. Case description.] / Alteraciones metabólicas y litiasis en pacientes con derivación ileal ortotópica. A propósito de un caso.

OBJECTIVE: Bacterial presence, anatomic anomalies and metabolic alterations increase the risk of stone formation in patients with neobladders. These patients sometimes require medical or surgical procedures. The aim of the current work is to analyze those alterations and medical treatment associated to it. METHODS: A case of a 66 yo male who had undergone a cystectomy with neobladder 3 years ago. Currently present with a staghorn stone on the right kidney. Past medical history of stone formation as well as double J calcification. RESULTS: The combination of medical and surgical treatment for stone was performed. Medical therapy will allow prevention of new stones. CONCLUSIONS: Metabolic and chronic infections in patients with neobladders treated should decreased the new stone formation in patients with neobladders.

OBJETIVO: La colonización bacteriana, las alteraciones anatómicas y las anomalías metabólicas aumentan el riesgo de litiasis en los pacientes con neovejiga, precisando en muchas ocasiones de un abordaje médico y quirúrgico complejo. El objetivo del trabajo es analizar dichas alteraciones y el tratamiento médico de las mismas. MÉTODOS: Se presenta el caso de un varón de 66 años con antecedente de cistectomía más derivación ortotópica desde hace tres años, el cual presenta litiasis coraliforme en riñón derecho. Antecedentes de varias litiasis, así como calcificación de doble J. RESULTADO: Mediante la combinación de tratamientos médicos y quirúrgicos se tratan las litiasis del paciente, siendo especialmente importante el manejo médico en la prevención de futuros eventos litiásicos. CONCLUSIONES: Diagnosticar y tratar las alteraciones metabólicas y las infecciones crónicas en pacientes con neovejiga puede reducir la aparición de litiasis en los pacientes con neovejiga.

Alteraciones metabólicas y litiasis en pacientes con derivación ileal ortotópica. A propósito de un caso / Metabolic alterations and lithiasis in patients with orthotopic ileal diversion. About a case

Objetivo: La colonización bacteriana, lasalteraciones anatómicas y las anomalías metabólicas aumentan el riesgo de litiasis en los pacientes con neovejiga,precisando en muchas ocasiones de un abordaje médicoy quirúrgico complejo. El objetivo del trabajo es analizardichas alteraciones y el tratamiento médico de las mismas.Métodos: Se presenta el caso de un varón de 66 añoscon antecedente de cistectomía más derivación ortotópicadesde hace tres años, el cual presenta litiasis coraliformeen riñón derecho. Antecedentes de varias litiasis, así comocalcificación de doble J. Resultado: Mediante la combinación de tratamientosmédicos y quirúrgicos se tratan las litiasis del paciente,siendo especialmente importante el manejo médico en laprevención de futuros eventos litiásicos.Conclusiones: Diagnosticar y tratar las alteracionesmetabólicas y las infecciones crónicas en pacientes conneovejiga puede reducir la aparición de litiasis en los pacientes con neovejiga.(AU)

Objetive: Bacterial presence, anatomicanomalies and metabolic alterations increase the risk ofstone formation in patients with neobladders. These patients sometimes require medical or surgical procedures.The aim of the current work is to analyze those alterationsand medical treatment associated to it.Methods: A case of a 66 yo male who had undergonea cystectomy with neobladder 3 years ago. Currently present with a staghorn stone on the right kidney. Past medicalhistory of stone formation as well as double J calcification.Results: The combination of medical and surgical treatment for stone was performed. Medical therapy will allowprevention of new stones.Conclusions: Metabolic and chronic infections in patients with neobladders treated should decreased the newstone formation in patients with neobladders.(AU)

Transurethral Drainage of Prostatic Abscess Using 120 W Holmium Laser Technology.

Introduction: Prostatic abscess is an infrequent but serious pathology that could be treated by ultrasound-guided puncture, transurethral resection, or open surgery. Case Report: We present a case of a 72-year-old male with a 3x5 cm prostatic abscess in the right lobe showed in abdominal computed tomography (CT). In the blood test, he presented coagulopathy. Urgent transurethral drainage by holmium laser was decided to be performed. It started with incision and opening of the right prostatic lobe with an energy of 1.2 J and a frequency of 20 Hz with a total power of 24 W. A 550-micron fiber was used for this technique. Coagulation of the area was performed with a power of 20 W. The postoperative course was uneventful. Conclusion: The holmium laser appears to be an effective alternative in the treatment of this pathology in patients with coagulation disorders by providing adequate hemostatic control.

Terapia de deprivación androgénica en cáncer de próstata avanzado. Estudio multicéntrico / Androgen deprivation therapy in advanced prostate cancer. Multicenter study

OBJETIVO: El cáncer de próstata (CP) avanzado es una entidad frecuente. Los objetivos de este trabajo son la presentación de una serie de pacientes con CP en tratamiento con Terapia de Deprivación Androgénica (TDA) en práctica clínica habitual y la determinación de parámetros asociados al desarrollo de resistencia a la castración (CPRC). MATERIAL Y MÉTODOS: Estudio multicéntrico, observacional, retrospectivo que analiza pacientes tratados con TDA desde enero 2016 hasta enero 2017. Análisis descriptivo de las variables clínicas más relevantes, análisis univariante y supervivencia libre de progresión mediante test Kaplan-Meier. RESULTADOS: Muestra 952 pacientes. Al diagnóstico del CP edad mediana 74 años. Mediana de PSA al diagnóstico de CP 23 ng/ml, al inicio TDA 20,2 ng/ml. El 80,2% de pacientes tenían biopsia al diagnóstico del CP: 28,2% grado pronóstico Gleason grupo 1, 38,7% grados 2 y 3 y 33,1% grados 4 y 5. Tratamiento inicial del CP: 75,9% TDA, prostatectomía radical 8,4% y radioterapia 15,1%. De los 952 pacientes, 281 (29,6%) cumplían criterios de CPRC. En este grupo el 21,7% alcanzó PSA indetectable (<0,1 ng/ml) con la TDA 20,2 frente al grupo no CPRC en el que lo alcanzaron el 59,9%. Encontramos mayor probabilidad de progresión a CPRC en pacientes con PSA al diagnóstico de CP > 30 ng/ml (p = 0,000, OR 2,78), grado pronóstico Gleason grupos 4-5 (p = 0,000, OR 2,33) y en aquellos que no alcanzan PSA indetectable tras TDA (p < 0,01, OR 3,32) variables que se relacionan con los tiempos de progresión a CPRC y especialmente al estadio metastásico. CONCLUSIONES: Se presenta una serie de pacientes CP avanzado en tratamiento con TDA que muestra heterogeneidad de características y de manejo según práctica clínica habitual. En nuestra serie el PSA elevado al diagnóstico, histología desfavorable y no alcanzar un PSA< 0,1 ng/ml tras la TDA se presentan como indicadores de progresión a estadio CPRC

OBJECTIVES: Advanced prostate cancer (PC) is a frequent entity. The objectives of this paper are the presentation of a sample of patients with PC undergoing treatment with androgen deprivation therapy (ADT) in usual clinical practice and the determination of parameters associated with the development of resistance to castration (CRPC). MATERIAL AND METHODS: Multicenter, observational, retrospective study that analyzes patients treated with ADT from January 2016 to January 2017. Descriptive analysis of the most relevant clinical variables and univariante analysis and progression times by Kaplan-Meier test. RESULTS: Sample of 952 patients. At PC diagnosis median age 74 years. Median PSA at PC diagnosis 23 ng/ml, when begining ADT 20.2 ng/ml. 80.2% of patients were biopsied at PC diagnosis: 28.2% Gleason score group 1, 38.7% groups 2 and 3 and 33.1% groups 4 and 5. Initial treatment of PC: 75.9% ADT, radical prostatectomy 8.4% and radiotherapy 15.1%. Of the 952 patients, 281 (29.6%) fulfilled CRPC criteria. In this group 21.7% achieved undetectable PSA (< 0.1 ng/ml) with ADT compared to the non-CRPC group in which it was 59.9%. Increased probability of progression to CRPC in: PSA >30ng/ml at PC diagnosis (p = 0.000, OR 2.78), Gleason score group 4-5 (p = 0.000, OR 2.33), and not to reach undetectable PSA after ADT (p < 0.001, OR 3.32). The initial ADT group presents progression to metastatic CRPC more rapidly in unfavourable histology and when not reached undetectable PSA after ADT. CONCLUSIONS: We present a sample of patients with advanced PC in treatment with ADT that shows heterogeneity in usual clinical practice. In our sample, elevated PSA at PC diagnosis, unfavorable histology and failure to achieve a PSA <0.1ng/ml after ADT is presented as an indicator of progression to the CRPC stage

[Androgen deprivation therapy in advanced prostate cancer. Multicenter study.] / Terapia de deprivación androgénica en cáncer de próstata avanzado. Estudio multicéntrico.

OBJECTIVES: Advanced prostate cancer (PC) is a frequent entity. The objectives of this paper are the presentation of a sample of patients with PC undergoing treatment with androgen deprivation therapy (ADT) in usual clinical practice and the determination of parameters associated with the development of resistance to castration (CRPC). MATERIAL AND METHODS: Multicenter, observational, retrospective study that analyzes patients treated with ADT from January 2016 to January 2017. Descriptive analysis of the most relevant clinical variables and univariante analysis and progression times by Kaplan-Meier test. RESULTS: Sample of 952 patients. At PC diagnosis median age 74 years. Median PSA at PC diagnosis 23 ng/ml, when begining ADT 20.2 ng/ml. 80.2% of patients were biopsied at PC diagnosis: 28.2% Gleason score group 1, 38.7% groups 2 and 3 and 33.1% groups 4 and 5. Initial treatment of PC: 75.9% ADT, radical prostatectomy 8.4% and radiotherapy 15.1%. Of the 952 patients, 281 (29.6%) fulfilled CRPC criteria.In this group 21.7% achieved undetectable PSA (group in which it was 59.9%. Increased probability of progression to CRPC in: PSA >30ng/ml at PC diagnosis (p=0.000, OR 2.78), Gleason score group 4-5 (p=0.000, OR 2.33), and not to reach undetectable PSA after ADT (p <0.001, OR 3.32). The initial ADT group presents progression to metastatic CRPC more rapidly in unfavourable histology and when not reached undetectable PSA after ADT. CONCLUSIONS: We present a sample of patients with advanced PC in treatment with ADT that shows heterogeneity in usual clinical practice. In our sample, elevated PSA at PC diagnosis, unfavorable histology and failure to achieve a PSA<0.1 ng/ml after ADT is presented as an indicator of progression to the CRPC stage.

OBJETIVO: El cáncer de próstata (CP) avanzado es una entidad frecuente. Los objetivos de este trabajo son la presentación de una serie de pacientes con CP en tratamiento con Terapia de Deprivación Androgénica (TDA) en práctica clínica habitual y la determinación de parámetros asociados al desarrollo de resistencia a la castración (CPRC).MATERIAL Y MÉTODOS: Estudio multicéntrico,  observacional, retrospectivo que analiza pacientes tratados con TDA desde enero 2016 hasta enero 2017. Análisis descriptivo de las variables clínicas más relevantes, análisis univariante y supervivencia libre de progresión mediante test Kaplan-Meier. RESULTADOS: Muestra 952 pacientes. Al diagnóstico del CP edad mediana 74 años. Mediana de PSA al diagnóstico de CP 23 ng/ml, al inicio TDA 20,2 ng/ml. El 80,2% de pacientes tenían biopsia al diagnóstico del CP: 28,2% grado pronóstico Gleason grupo 1, 38,7% grados 2 y 3 y 33,1% grados 4 y 5. Tratamiento inicial del CP: 75,9% TDA, prostatectomía radical 8,4% y radioterapia 15,1%.De los 952 pacientes, 281 (29,6%) cumplían criterios de CPRC. En este grupo el 21,7% alcanzó PSA indetectable (<0,1 ng/ml) con la TDA 20,2  frente al grupo no CPRC en el que lo alcanzaron el 59,9%. Encontramos mayor probabilidad de progresión a CPRC en pacientes con PSA al diagnóstico de CP >30 ng/ml (p=0,000, OR 2,78), grado pronóstico Gleason grupos 4-5 (p=0,000, OR 2,33) y en aquellos que no alcanzan PSA indetectable tras TDA (p<0,01, OR 3,32) variables que se relacionan con los tiempos de progresión a CPRC y especialmente al estadio metastásico. CONCLUSIONES: Se presenta una serie de pacientes CP avanzado en tratamiento con TDA que muestra heterogeneidad de características y de manejo según práctica clínica habitual. En nuestra serie el PSA elevado al diagnóstico, histología desfavorable y no alcanzar un PSA<0,1 ng/ml tras la TDA se presentan como indicadores de progresión a estadio CPRC.

[Technical and peri-operative differences between the transvesical and extravesical approach in laparoscopic repair of vesico-vaginal fistula.] / Diferencias técnicas y peri-operatorias entre el abordaje transvesical y extravesical en la reparación laparoscópica de la fístula vesico-vaginal.

OBJECTIVE: In the laparoscopic/robotic repair (L/R R) of Vesico-vaginal Fistulas (VVF) two types of transvesical and extravesical approaches are used.However, no direct comparisons exist between both surgical approaches Moreover, a lack of clinical guidelines is currently ongoing. Therefore, the selection of the type of approach is based on the preferences of the surgeon without considering the characteristics of each case.In order to provide recommendations for the selection of the appropriate technique for each patient, we designed a study that identifies and evaluates differences between the Transvesical and Extravesical approaches in the L/R R of the VVF. PATIENTS AND METHODS: A total of 9 patients withVVF were included. Four patients underwent transvesicaltechnique and the rest the Extravesical technique. Thevariables in each group were recorded. Surgical stepswere selected with technical differences to be analyzed(identification of the fistula, dissection of the vesico-vaginalplane, cystotomy, maneuvers of exposure and cystorrhaphy). RESULTS: Short operative times and catheterization times were recorded in the Extravesical approach. Intraoperative blood loss was minimal in both groups, the hospital stay was very similar and no peri and post-operativec omplications were reported. In all cases the fistula was resolved and there have been no recurrences in a mean follow-up of 35 months. Technically, Extravesical approach minimizes the size of the cystotomy, decreases suture time, does not require maneuvers for adequate exposure, and simplifies cystorrhaphy with respect to Transvesical technique, at the expense of requiring further dissection and having a slight difficulty in locating the fistula. Transvesical technique simplifies the locationof the fistula and allows better intravesical visualization. CONCLUSION: In the L/R R of the VVF, the Extravesicaltechnique offers technical and perioperative advantages,so it must be the technique of choice for most VVFwith indication of abdominal approach. Transvesicaltechnique should be reserved for recurrent, recurrent,inflammatory fistulas, with difficulties identifying the fistulous orifice, close to ureteric orifice and with imminent need for ureteral reimplantation.

OBJETIVO: En la reparación laparoscópica/robótica (RL/R) de las Fístulas Vesico-vaginales (FVV) se emplean dos tipos de abordajes el Transvesical y el Extravesical, sin embargo no existen comparaciones directas entre ambos abordajes ni tampoco disponemos de guías clinicas, por lo cual la selección del tipo de abordaje se basa en las preferencias del cirujano sin considerarse las características de cada caso. Con el objetivo de definir recomendaciones para la selección de la técnica apropiada para cada paciente, diseñamos un estudio que identifique y evalúe las diferencias entre los abordajes Transvesical y Extravesical en la RL/R de la FVV.PACIENTES Y MÉTODOS: Un total de 9 pacientes con FVV fueron incluídas. A cuatro pacientes se les realizó técnica Transvesical y el resto la técnica Extravesical. Se registraron las variables en cada grupo. Se seleccionaron los pasos quirúrgicos con diferencias técnicas para ser analizados (identificación de la fístula, disección del plano vesico-vaginal, cistotomía, maniobras de exposición y cistorrafia). RESULTADOS: Se registraron menores tiempos quirúrgicos y tiempos de sondaje en el abordaje Extravesical. El sangrado intraoperatorio fue mínimo en ambos grupos,la estancia hospitalaria fue muy semejante y tampoco se reportaron complicaciones peri y post-operatorias. En todos los casos se resolvió la fístula y no han habido recurrencias en una media de seguimiento superior 35 meses. Técnicamente la vía Extravesical minimiza el tamaño de la cistotomía, disminuye el tiempo de sutura,no requiere de maniobras para la exposición adecuada,y simplifica la cistorrafia con respecto a la técnica Transvesical, a expensas de requerir mayor disección y tener una discreta dificultad para localizar la fístula.La técnica Transvesical simplifica la localización de la fístula y permite mejor visualización intravesical.CONCLUSIÓN: En la RL/R de la FVV, la técnica Extravesical ofrece ventajas técnicas y perioperatorias, por lo cual debe ser la técnica de elección para la mayoría de las FVV con indicación de abordaje abdominal. La técnica Transvesical se debe reservar para fístulas recurrentes,múltiples, inflamatorias, de dificil localización del orificio fistuloso, con excesiva proximidad de los meatos y con inminente necesidad de reimplante ureteral.

Diferencias técnicas y peri-operatorias entre el abordaje transvesical y extravesical en la reparación laparoscópica de la fístula vesico-vaginal / Technical and peri-operative differences between the transvesical and extravesical approach in laparoscopic repair of vesico-vaginal fistula

OBJETIVO: En la reparación laparoscópica/robótica (RL/R) de las Fístulas Vesico-vaginales (FVV) se emplean dos tipos de abordajes el Transvesical y el Extravesical, sin embargo no existen comparaciones directas entre ambos abordajes ni tampoco disponemos de guías clinicas, por lo cual la selección del tipo de abordaje se basa en las preferencias del cirujano sin considerarse las características de cada caso. Con el objetivo de definir recomendaciones para la selección de la técnica apropiada para cada paciente, diseñamos un estudio que identifique y evalúe las diferencias entre los abordajes Transvesical y Extravesical en la RL/R de la FVV. PACIENTES Y MÉTODOS: Un total de 9 pacientes con FVV fueron incluídas. A cuatro pacientes se les realizó técnica Transvesical y el resto la técnica Extravesical. Se registraron las variables en cada grupo. Se seleccionaron los pasos quirúrgicos con diferencias técnicas para ser analizados (identificación de la fístula, disección del plano vesico-vaginal, cistotomía, maniobras de exposición y cistorrafia). RESULTADOS: Se registraron menores tiempos quirúrgicos y tiempos de sondaje en el abordaje Extravesical. El sangrado intraoperatorio fue mínimo en ambos grupos,la estancia hospitalaria fue muy semejante y tampoco se reportaron complicaciones peri y post-operatorias. En todos los casos se resolvió la fístula y no han habido recurrencias en una media de seguimiento superior 35 meses. Técnicamente la vía Extravesical minimiza el tamaño de la cistotomía, disminuye el tiempo de sutura,no requiere de maniobras para la exposición adecuada,y simplifica la cistorrafia con respecto a la técnica Transvesical, a expensas de requerir mayor disección y tener una discreta dificultad para localizar la fístula.La técnica Transvesical simplifica la localización de la fístula y permite mejor visualización intravesical. CONCLUSIÓN: En la RL/R de la FVV, la técnica Extravesical ofrece ventajas técnicas y perioperatorias, por lo cual debe ser la técnica de elección para la mayoría de las FVV con indicación de abordaje abdominal. La técnica Transvesical se debe reservar para fístulas recurrentes,múltiples, inflamatorias, de dificil localización del orificio fistuloso, con excesiva proximidad de los meatos y con inminente necesidad de reimplante ureteral

OBJECTIVE: In the laparoscopic/robotic repair (L/R R) of Vesico-vaginal Fistulas (VVF) two types of transvesical and extravesical approaches are used.However, no direct comparisons exist between both surgical approaches Moreover, a lack of clinical guidelines is currently ongoing. Therefore, the selection of the type of approach is based on the preferences of the surgeon without considering the characteristics of each case.In order to provide recommendations for the selection of the appropriate technique for each patient, we designed a study that identifies and evaluates differences between the Transvesical and Extravesical approaches in the L/R R of the VVF. PATIENTS AND METHODS: A total of 9 patients withVVF were included. Four patients underwent transvesicaltechnique and the rest the Extravesical technique. Thevariables in each group were recorded. Surgical stepswere selected with technical differences to be analyzed(identification of the fistula, dissection of the vesico-vaginalplane, cystotomy, maneuvers of exposure and cystorrhaphy). RESULTS: Short operative times and catheterization times were recorded in the Extravesical approach. Intraoperative blood loss was minimal in both groups, the hospital stay was very similar and no peri and post-operativec omplications were reported. In all cases the fistula was resolved and there have been no recurrences in a mean follow-up of 35 months. Technically, Extravesical approach minimizes the size of the cystotomy, decreases suture time, does not require maneuvers for adequate exposure, and simplifies cystorrhaphy with respect to Transvesical technique, at the expense of requiring further dissection and having a slight difficulty in locating the fistula. Transvesical technique simplifies the locationof the fistula and allows better intravesical visualization. CONCLUSION: In the L/R R of the VVF, the Extravesicaltechnique offers technical and perioperative advantages,so it must be the technique of choice for most VVFwith indication of abdominal approach. Transvesicaltechnique should be reserved for recurrent, recurrent,inflammatory fistulas, with difficulties identifying the fistulous orifice, close to ureteric orifice and with imminent need for ureteral reimplantation

Hidrocele infectado / Infected hidrocele

No disponible

[Neurofibromas in the urogenital system: Report of two cases and literature review.] / Neurofibromas en el sistema urogenital: presentación de dos casos clínicos y revisión de la bibliografía.

OBJECTIVE: We introduce two cases of a 46 and 66-year-old patient, both diagnosed with pelvic neurofibroma (One located in a seminal vesicle, the other in the bladder). The first patient had been diagnosed with Neurofibromatosis type 1 while the other was diagnosed with a sporadic neurofibroma. METHODS: During a study for lower urinary tract symptoms referred, these patients were diagnosed seminal vesicle and bladder neurofibroma, respectively, using image and histological tests. RESULTS: The histopathological and inmunohistochemical characteristics of these benign tumors gave the definitive diagnosis. CONCLUSIONS: Pelvic neurofibromas are a rare entity in this anatomical location. They can be associated with Neurofibromatosis type 1 or not. We get to their diagnosis by an anatomopathological study. Conservative management is the usual procedure, being mandatory a clinical follow-up that must be coupled with image tests.

Neurofibromas en el sistema urogenital: presentación de dos casos clínicos y revisión de la bibliografía / Neurofibromas in the urogenital system: Report of two cases and literature review

OBJETIVO: Se realizó una revisión bilbiográfica en base a dos casos de pacientes de 46 y 66 años diagnosticados de neurofibromas pélvicos (en vesícula seminal y vejiga), siendo uno de ellos esporádico y otro asociado a Neurofibromatosis tipo 1. MÉTODOS: En el contexto del estudio de los pacientes por síntomas del tracto urinario inferior mediante pruebas de imagen y con el estudio anatomopatológico se llegó al diagnóstico de neurofibroma de vesícula seminal y vejiga respectivamente. RESULTADOS: Las características histopatológicas así como las pruebas inmunohistoquímicas permitieron llegar al diagnóstico de este tumor de comportamiento benigno. CONCLUSIONES: Los neurofibromas pélvicos son una entidad rara en esta localización y que pueden aparecer asociados o no a Neurofibromatosis tipo 1. Su diagnóstico se basa en el estudio anatomopatológico y su tratamiento es conservador, precisando un seguimiento clínico y mediante pruebas de imagen

OBJECTIVE: We introduce two cases of a 46 and 66-year-old patient, both diagnosed with pelvic neurofibroma (One located in a seminal vesicle, the other in the bladder). The first patient had been diagnosed with Neurofibromatosis type 1 while the other was diagnosed with a sporadic neurofibroma. METHODS: During a study for lower urinary tract symptoms referred, these patients were diagnosed seminal vesicle and bladder neurofibroma, respectively, using image and histological tests. RESULTS: The histopathological and inmunohistochemical characteristics of these benign tumors gave the definitive diagnosis. CONCLUSIONS: Pelvic neurofibromas are a rare entity in this anatomical location. They can be associated with Neurofibromatosis type 1 or not. We get to their diagnosis by an anatomopathological study. Conservative management is the usual procedure, being mandatory a clinical follow-up that must be coupled with image tests

Transvaginal adjustable tape: an adjustable mesh for surgical treatment of female stress urinary incontinence.

After transvaginal adjustable tape, approximately 15% of patients still suffer incontinence, and voiding dysfunction is present in a relatively important number of patients. Transvaginal adjustable tape (TVA) permits postoperative readjustment of tension, suggesting that better results could be obtained. Sixty-four incontinent women received TVA. Patients were monitored 1, 6, and 12 months post-surgery and annually thereafter by medical history, cough stress test, flowmetry and post-void residual test (PVR), incontinence quality of life, International Consultation on Incontinence Questionnaire-Short Form, and Patient Global Impressions of Improvement (PGI-I) questionnaires. After adjustment, all patients rendered continent, and none had PVR. On no occasion was vesical catheterization or uretholysis necessary. Mean follow-up was 40+/-12.9 months. Objective and subjective cure rate were 94% and 56%, respectively. Qmax was 22.3+/-9.9 ml/s. The PGI-I questionnaire showed 94% of patients to be better or very much better than before. Our data suggest that with TVA tape, better results can be obtained, furthermore, without increasing surgical complications.

[Metachronous adrenal metastasis in two patients undergoing radical nephrectomy for primary renal cell carcinoma]. / Metástasis suprarrenal metacrónica en 2 pacientes sometidos a nefrectomía radical por carcinoma de células renales primario.

OBJECTIVES: We report two exceptional cases of metachronous adrenal metastasis of renal cell carcinomas and perform a bibliographic review. After the evaluation of various features such as frequency, etiopathogenesis, diagnosis and follow-up of these patients we conclude that these metastases are rare, and they usually appear late in the evolution of patients with low stage renal cell carcinoma. RESULTS/CONCLUSIONS: Once reviewed the treatment and checked the absence of guidelines for the therapeutic management of these patients we propose surgery for the adrenal metastasis as well as adjuvant treatment with immunotherapy.

Metástasis suprarrenal metacrónica en 2 pacientes sometidos a nefrectomía radical por carcinoma de células renales primario / No disponible

OBJETIVOS/MÉTODOS: Presentamos dos casos excepcionales de metástasis suprarrenales metacrónicas de carcinoma de células renales y revisamos la literatura existente. Valorados distintos aspectos como la frecuencia, etiopatogenia, diagnóstico y seguimiento de estos pacientes concluimos que estas metástasis son poco frecuentes y suelen presentarse tardías en su evolución en pacientes con CCR con bajo estadios anatomopatológicos. RESULTADOS/CONCLUSIONES: Revisado el trata- miento y constatando que no hay directrices en cuanto al manejo terapéutico de estos pacientes con metástasis proponemos la cirugía de la metástasis suprarrenal así como el tratamiento adyuvante con inmunoterapia (AU)

OBJECTIVES: We report two exceptional cases of metachronous adrenal metastasis of renal cell carcinomas and perform a bibliographic review. After the evaluation of various features such as frequency, etiopathogenesis, diagnosis and follow-up of these patients we conclude that these metastases are rare, and they usually appear late in the evolution of patients with low stage renal cell carcinoma. RESULTS/CONCLUSIONS: Once reviewed the treatment and checked the absence of guidelines for the therapeutic management of these patients we propose surgery for the adrenal metastasis as well as adjuvant treatment with immunotherapy (AU)

[Subepithelial hematoma of the renal pelvis producing a filling defect in the upper urinary tract radiological study]. / Hematoma subepiteual de la pelvis renal como causa de defecto de repleción en el estudio radiológico del tracto urinario superior.

OBJECTIVES: After taking care of a patient with suspicion of upper urinary tract neoplasia which was finally diagnosed of renal pelvis subepithelial hematoma (Antopol-Goldman lesion), we decided to review such unfrequent pathology with the aim to summarize its main characteristics. METHODS: The patient presented clinically and radiologically as an upper urinary tract tumor and underwent nephroureterectomy. Past history was significant for oral anticoagulative treatment after deep vein thrombosis. RESULTS: Pathologic study of the nephrectomy specimen reported absence of urothelial tumor and presence of a subepithelial hematoma of the renal pelvis, which explained both clinical manifestations and radiological findings. Our case is very similar to the other 27 published in the bibliography. CONCLUSIONS: Subepithelial hematoma of the renal pelvis is a benign lesion, more frequent in females, which appears between the fourth and sixth decades of life. Not much is known about its etiopathogenesis, it probably is a multifactorial process. It simulates an upper urinary tract urothelial tumor, both clinically and radiologically, and so is treated in most published cases. It is necessary to know this entity as possible differential diagnosis of upper urinary tract radiological study filling defects to avoid non necessary nephrectomies.

Hematoma subepitelial de la pelvis renal como causa de defecto de repleción en el estudio radiológico del tracto urinario superior / Suepithelial hematoma of the renal pelvis producing a filling defect in the upper urinary tract radiological study

OBJETIVO: Comunicar un caso de uropatíaobstructiva que evolucionó a anulación funcional renalpor lesión pseudotumoral en uréter iliaco.METODOS: Varón de 66 años en estudio por HBP, presentaepisodio autolimitado de hematuria monosintomática.RESULTADOS: En estudio ecográfico se detecta ureteropielocaliectasiagrado II RD; U.I.V. demuestra anulaciónfuncional RD.Citología de orina compatible con carcinomade células transicionales de bajo grado. Se realizanefrostomía percutánea que confirma la pérdida funcionalirreversible. La pielografía descendente muestra defectode replección a nivel de uréter iliaco derecho. El pacientees intervenido quirúrgicamente practicándosele nefroureterectomíaradical con cistectomía perimeática, con buenaevolución postoperatoria. El dictamen histopatológico dela pieza es de pielonefritis crónica y lesión inflamatoriaparietal ureteral que oblitera la luz con infiltrado inflamatorio,erosión de urotelio y presencia de actinomices.CONCLUSIONES: La actinomicosis es una infección bacterianacrónica cuyo patógeno más común es A.israelii.Se encuentra como comensal en la cavidad oral y tubodigestivo y la. afectación clínica más frecuente es laregión cervicofacial (60% casos) La infección del tractourinario es excepcional y en la evolución del paciente alargo plazo no se ha constatado ningún otro foco

OBJECTIVES: To report one case of pseudotumoral lesion of the iliac ureter with obstructive uropathy leading to loss of function of the renal unit. METHODS: 66-year-old male being studied for BPH who presents with a self-limited monosymptomatic hematuria. RESULTS: Renal ultrasound detected grade II pyelocaliectasis of the right kidney. IVU showed absence of function of the right kidney. Urine cytology was consistent with low-grade transitional cell carcinoma. Percutaneous nephrostomy was performed confirming irreversible function loss. Antegrade pyelography showed a filling defect in the right iliac ureter. Radical nephroureterectomy with bladder cuff was carried out with good results. Pathology reported chronic pyelonephritis and parietal inflammatory lesion of the ureter obliterating the lumen with inflammatory infiltrates, urothelial erosion and presence of actinomyces. CONCLUSIONS: Actinomycosis is a chronic bacterial infection, with A. israeli being the most common pathogen. It is part of the normal flora of the oral cavity and GI tract, and cervical-facial region is the most frequent clinical involvement (60% of the cases). Urinary tract infection is exceptional. No other focus was found in the long-term follow-up

[Malacoplakia within a female urethral diverticulum]. / Malacoplaquia en divertículo uretral femenino.

OBJECTIVES: We report one case of malakoplakia within a female urethral diverticulum. METHODS: 33-year-old patient who consulted for an asymptomatic vaginal tumor. Physical examination, blood and urine analysis and microbiology tests, as well as urethrocystoscopy and intravenous pyelogram were performed. With the diagnosis of urethral diverticulum we undertook surgical excision through a vaginal approach. RESULTS: Pathology revealed the typical characteristics of malakoplakia within the diverticular lumen. CONCLUSIONS: Malakoplakia is an infrequent inflammatory disease which involves the urinary tract in most cases. Urethra location is exceptional.